< Back to companies

AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. Its full-stack, AI-powered drug discovery platform integrates modern technologies from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning, and hyper-scale data science. We partner with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce costs, and tackle the toughest problems in drug development.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2020
Website
www.abcellera.com/

Categories

AI / MLDrug Discovery/DevelopmentPrecision Medicine/Diagnostics

Disease Areas

Technologies

AI-driven Drug DiscoveryDrug Discovery PlatformMachine LearningSingle-Cell Analysis
Only accessible to MedStartr community members. Join now

What do you think of AbCellera?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now